[1] Du, Daohai; Xu, Dandan; Zhu, Licheng; Stazi, Giulia; Zwergel, Clemens; Liu, Yanli; Luo,Zhongyuan; Li, Yuanqing; Zhang, Yuanyuan; Zhu, Kongkai; Ding, Yiluan; Liu, Jingqiu; Fan, Shijie;Zhao, Kaiyan; Zhang, Naixia; Kong, Xiangqian; Jiang, Hualiang; Chen, Kaixian; Zhao, Kehao;Valente, Sergio; Min, Jinrong; Duan, Wenhu; Luo, Cheng ; Structure-Guided Development of Small- Molecule PRC2 Inhibitors Targeting EZH2-EED Interaction, Journal of Medicinal Chemistry, 2021,64(12): 8194-8207. [2] Moody, James D.; Levy, Shiri; Mathieu, Julie; Xing, Yalan; Kim, Woojin; Dong, Cheng;Tempel, Wolfram; Robitaille, Aaron M.; Dang, Luke T.; Ferreccio, Amy; Detraux, Damien; Sidhu,Sonia; Zhu, Licheng; Carter, Lauren; Xu, Chao; Valensisi, Cristina; Wang, Yuliang; Hawkins, R.David; Min, Jinrong; Moon, Randall T.; Orkin, Stuart H.; Baker, David; Ruohola-Baker, Hannele ;First critical repressive H3K27me3 marks in embryonic stem cells identified using designedprotein inhibitor, Proceedings of the National Academy of Sciences of the United States of America, 2017, 114(38): 10125-10130. [3] Cheng Dong; Guangping Dong; Li Li; Licheng Zhu; Jinrong Min ; An asparagine/glycineswitch governs product specificity of human N-terminal methyltransferase NTMT2, Communications Biology, 2018, 1: 0-183. [4] 朱立成, 罗辉, 任悍. 植物防御素结构与功能及其抗真菌机制研究进展, 生物技术通报, 2014,(03): 9-14. |
